Literature DB >> 11426963

Characteristics of ovarian and uterine cancers in a cohort of in vitro fertilization patients.

A Venn1, P Jones, M Quinn, D Healy.   

Abstract

OBJECTIVE: The aim of this study was to describe the features of cancers of the uterus, ovary, and other uterine adnexae in a large cohort of in vitro fertilization (IVF) patients and to thereby assist gynecologic oncologists in counseling patients with a history of infertility.
METHODS: Record-linkage to population-based cancer registries was used to determine the incidence of invasive cancer in a cohort of 29,700 IVF patients. Pathology reports were made available by the cancer registries and reviewed blind to IVF treatment status. Patient information was abstracted from IVF clinic records.
RESULTS: Twelve cancers of the uterus and 13 cancers of the ovary and other uterine adnexae were identified and pathology reports were reviewed for all but 1. Patients ranged in age at diagnosis from 28 to 48 years. Five cancers were diagnosed within 8 months of referral for IVF or IVF treatment; the others were diagnosed between 1 and 12 years later. The ovarian cancers were of the following histologic types: serous (4), mucinous (1), seromucinous (1), endometrioid (3), clear cell (2), and unknown type (1). A choriocarcinoma of the fallopian tube was diagnosed in a woman with a history of tubal infertility. Cancers of the uterus included endometrial adenocarcinomas (8), stromal sarcomas (2), and leiomyosarcomas (2). Ovarian cancer was diagnosed in a woman with Bloom's syndrome, a rare autosomal recessive disorder associated with increased cancer risk.
CONCLUSION: Cancer cases in this large, well-defined cohort of IVF patients show a broad range of patient and tumor characteristics. We found an increased incidence of uterine sarcoma in women with a history of infertility. Increased ascertainment of preexisting cancers in the course of infertility investigations and management is to be expected. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11426963     DOI: 10.1006/gyno.2001.6209

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

Review 1.  Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility.

Authors:  Alkistis Skalkidou; Theodoros N Sergentanis; Spyros P Gialamas; Marios K Georgakis; Theodora Psaltopoulou; Marialena Trivella; Charalampos S Siristatidis; Evangelos Evangelou; Eleni Petridou
Journal:  Cochrane Database Syst Rev       Date:  2017-03-25

2.  Synchronous leiomyosarcoma and fibroma in a single ovary: A case report and review of the literature.

Authors:  Meng He; Yan-Jie Deng; Dan-Yi Zhao; Yang Zhang; Tao Wu
Journal:  Oncol Lett       Date:  2016-02-17       Impact factor: 2.967

Review 3.  Does ovulation induction increase the risk of gynecological cancer?

Authors:  H N Sallam; M Abdel-Bak; N H Sallam
Journal:  Facts Views Vis Obgyn       Date:  2013

4.  Identifying stably expressed housekeeping genes in the endometrium of fertile women, women with recurrent implantation failure and recurrent miscarriages.

Authors:  Linden Stocker; Felino Cagampang; Ying Cheong
Journal:  Sci Rep       Date:  2017-11-01       Impact factor: 4.379

Review 5.  Do the Fertility Drugs Increase the Risk of Cancer? A Review Study.

Authors:  Zohre Momenimovahed; Safoura Taheri; Azita Tiznobaik; Hamid Salehiniya
Journal:  Front Endocrinol (Lausanne)       Date:  2019-05-24       Impact factor: 5.555

6.  Gestational choriocarcinoma diagnosed with spontaneous splenic rupture after pregnancy induced by in vitro fertilization: a case report.

Authors:  Mehmet Yürüyen; Ozcan Yildiz; Cigdem Papila; Nukhet Tuzuner
Journal:  Cases J       Date:  2009-05-15

7.  The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium.

Authors:  A S Felix; L S Cook; M M Gaudet; T E Rohan; L J Schouten; V W Setiawan; L A Wise; K E Anderson; L Bernstein; I De Vivo; C M Friedenreich; S M Gapstur; R A Goldbohm; B Henderson; P L Horn-Ross; L Kolonel; J V Lacey; X Liang; J Lissowska; A Magliocco; M L McCullough; A B Miller; S H Olson; J R Palmer; Y Park; A V Patel; J Prescott; R Rastogi; K Robien; L Rosenberg; C Schairer; X Ou Shu; P A van den Brandt; R A Virkus; N Wentzensen; Y-B Xiang; W-H Xu; H P Yang; L A Brinton
Journal:  Br J Cancer       Date:  2013-01-24       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.